Menu
Recruiting NCT07501689

Using Middle School Science Teachers to Address Cancer Health Disparities

No phase Interventional Cancer Risk Factors Cancer Prevention

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: CARES4You Curriculum.
Who it may be relevant to
Registry conditions: Cancer Risk Factors, Cancer Prevention. Basic parameters: from 10 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Using Middle School Science Teachers to Address Health Disparities

Overview

The CARES4You study is testing a middle school science curriculum designed to teach students about cancer risk and prevention. The lessons are taught by regular science teachers during class time and are aligned with national science education standards. The curriculum includes six units (14 lessons) that help students learn about cancer, understand how lifestyle and environmental factors influence risk, and think about ways to make healthy choices. The study will take place in 10 public middle schools in New York City. Some schools will begin using the CARES4You curriculum right away, while others will continue with their usual science lessons and receive the program later. Researchers will compare the two groups of schools. The main goal of the study is to see whether the curriculum increases students' intentions to engage in healthy behaviors that may reduce cancer risk. The study will also examine whether students talk more with their caregivers about cancer risk and prevention after participating in the program. Caregivers may also report on some health behaviors in the household. If the program is effective, CARES4You could provide schools with a practical and sustainable way to teach cancer prevention and promote healthy behaviors among adolescents and their families.

Detailed description

The investigators will evaluate whether the CARES4You intervention modifies health-promoting behavior intentions among middle school students in New York City.

Participants in the control arm will receive the exact same 5-week educational curriculum as those in the intervention arm.

Participants will:

1. Be assigned to either the control group or the study group; both will receive the same cancer educational curriculum over 5 weeks. 2. Receive weekly classroom lessons and labs over 5 weeks. 3. Students will complete a survey before and after the administration of the curriculum intervention. These questionnaires evaluate students' change in knowledge related to the curriculum, and questions about their cancer risk behaviors, and communication styles at home. 4. Caregivers of students in the intervention schools only will complete a survey at one time point and receive a $40 electronic gift card for completing the survey at the end of the curriculum implementation phase. 5. Instructors will complete a training program evaluation and a post-curriculum evaluation to assess the impact of the curriculum on their students.

Interventions

  • Behavioral CARES4You Curriculum
    CARES4You is a teacher-delivered middle school science curriculum focused on cancer risk and prevention. Public middle schools in New York City self-select into either an immediate-intervention group or a delayed-intervention group. In both groups, grade-level science teachers deliver the same curriculum during regular 50-minute science classes over approximately five weeks. The program includes six units delivered across 14 lessons, typically taught 4-5 days per week. Units cover Cancer Genetic

Primary outcome measures

  • Change in students' intention to engage in health-promoting behaviors following the completion of the curriculum. [Time frame: Baseline, End of Study (6 weeks)]
Secondary outcome measures (1)
  • Number of student participants and caregiver participants who initiate cancer risk communication in the household. [Time frame: End of Study (6 weeks)]

Eligibility criteria

Inclusion criteria

  • Adolescents:
  • Age 10-13
  • Attends a NYC Public Middle School
  • Resides in one of the study's four target PPA's
  • Parents/Caregivers:
  • 18 years of age or older
  • Has at least one child registered for middle school in NYC that resides with them
  • Resides in one of the study's four target PPA's
  • Able to provide informed consent

Exclusion criteria

  • Adolescents: Students who do not attend one of the participating NYC Public Middle Schools
  • Parents/Caregivers: Caregivers who do not have a child that attends one of the participating NYC Public Middle Schools

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 5 centers
  • Dock Street School for STEAM Studies District: 13 School #: K313 — Brooklyn
  • P.S/I.S. 173 District: 6 School #: 173 — New York
  • I.S. 145 Joseph Pulitzer District 30 School #: Q145 — Queens
  • Metropolitan Expeditionary Learning School District 28 School #: Q167 — Queens
  • Jonas Bronck Academy District: 7 School #: X043 — The Bronx

Publications

  • Komsany A, McCooty K, Fox J, Shah U, Leak TM, McDonald JA, Terry MB, Soroka O, Phillips E. Integrating Cancer Prevention into Science Education: Development of the CARES4You School-based Curriculum. J Cancer Educ. 2025 Dec 22:10.1007/s13187-025-02812-x. doi: 10.1007/s13187-025-02812-x. Online ahead of print. PMID 41428312

Identifiers

NCT: NCT07501689 · 22-12025527 · U54CA280808-01 · NYC DOE 4928

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗